Related Experiment Video
Updated: Dec 12, 2025
08:49
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
14.3K
KLF4 Exerts Sedative Effects in Pentobarbital-Treated Mice
Ziqian Cheng1, Wei Yang1, Bingjin Li2
1Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, Second Hospital of Jilin University, 218 Ziqiang Street, Changchun, 130041, People's Republic of China.
Journal of Molecular Neuroscience : MN
|August 14, 2020
Summary
Krüppel-like factor 4 (KLF4) promotes sedation by influencing brain regions involved in sleep. This transcription factor regulates key proteins, suggesting potential therapeutic applications for sleep disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Sleep Science
Background:
- Krüppel-like factor 4 (KLF4) is a transcription factor involved in various biological processes.
- KLF4's role in neuroinflammation, regeneration, proliferation, and apoptosis suggests potential links to neurological disorders.
- The specific function of KLF4 in regulating immediate behavioral processes like sleep remains largely unexplored.
Purpose of the Study:
- To investigate the role of KLF4 in sedation and its underlying mechanisms.
- To explore the effects of KLF4 on sleep-related behaviors and gene expression in the brain.
Main Methods:
- Behavioral assays were used to assess sedation.
- Western blot and immunohistochemical techniques were employed to examine protein expression.
- Experiments involved pentobarbital-treated mice with KLF4 overexpression.
Main Results:
- Overexpression of KLF4 prolonged the duration of loss of righting reflex (LORR) in mice.
- KLF4 modulated c-Fos expression in key hypothalamic nuclei (LH, VLPO, TMN).
- KLF4 altered the expression of p53 and STAT3 in the hypothalamus.
Conclusions:
- KLF4 appears to exert sedative effects by regulating p53 and STAT3 expression.
- These findings suggest that KLF4 plays a role in the regulation of sleep.
- KLF4 ligands may represent a novel therapeutic strategy for treating sleep disorders.
Related Concept Videos
01:20Sedatives and Hypnotics Drugs: Barbiturates
747
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
747
01:24Parenteral Anesthetics: Overview
470
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
470
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
378
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
378
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.0K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.0K
01:23Sedatives and Hypnotics: Overview
1.1K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.1K
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
585
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
585